Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Virus Latency | 3 | 2017 | 251 | 1.77 | Why? |
| Histones | 2 | 2018 | 371 | 1.12 | Why? |
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 33 | 0.88 | Why? |
| Chromatin | 2 | 2017 | 107 | 0.81 | Why? |
| Optical Imaging | 1 | 2020 | 197 | 0.76 | Why? |
| Retroviridae | 1 | 2018 | 49 | 0.75 | Why? |
| Protein Methyltransferases | 1 | 2017 | 2 | 0.74 | Why? |
| DNA Modification Methylases | 1 | 2017 | 11 | 0.73 | Why? |
| Chromatin Assembly and Disassembly | 1 | 2017 | 62 | 0.70 | Why? |
| Histone Demethylases | 1 | 2017 | 31 | 0.70 | Why? |
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 82 | 0.65 | Why? |
| Epigenomics | 1 | 2018 | 139 | 0.65 | Why? |
| Sirtuin 1 | 1 | 2017 | 100 | 0.65 | Why? |
| DNA | 2 | 2018 | 778 | 0.61 | Why? |
| Stem Cells | 1 | 2020 | 595 | 0.56 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.56 | Why? |
| HIV-1 | 3 | 2017 | 3365 | 0.53 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.51 | Why? |
| Cell Phone | 1 | 2020 | 750 | 0.50 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.45 | Why? |
| Transcription, Genetic | 1 | 2017 | 1326 | 0.44 | Why? |
| Lysine | 2 | 2018 | 153 | 0.33 | Why? |
| DNA, Viral | 1 | 2017 | 2521 | 0.32 | Why? |
| RNA Interference | 2 | 2020 | 534 | 0.30 | Why? |
| Immunologic Memory | 1 | 2017 | 3362 | 0.29 | Why? |
| Anti-HIV Agents | 1 | 2017 | 2209 | 0.28 | Why? |
| Promoter Regions, Genetic | 2 | 2017 | 823 | 0.26 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.25 | Why? |
| T-Lymphocytes | 2 | 2017 | 6670 | 0.25 | Why? |
| Protein Interaction Maps | 2 | 2020 | 1333 | 0.24 | Why? |
| CRISPR-Cas Systems | 2 | 2021 | 1397 | 0.23 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.21 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2017 | 5837 | 0.21 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.19 | Why? |
| Lysine Acetyltransferases | 1 | 2018 | 2 | 0.19 | Why? |
| Protein Stability | 2 | 2020 | 756 | 0.19 | Why? |
| Forkhead Box Protein O1 | 1 | 2017 | 31 | 0.18 | Why? |
| Azepines | 1 | 2017 | 17 | 0.18 | Why? |
| Acetylation | 1 | 2018 | 124 | 0.18 | Why? |
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 239 | 0.18 | Why? |
| Chromatin Immunoprecipitation | 1 | 2017 | 53 | 0.18 | Why? |
| Histone Deacetylases | 1 | 2018 | 37 | 0.18 | Why? |
| CD28 Antigens | 1 | 2017 | 39 | 0.18 | Why? |
| Retroelements | 1 | 2017 | 27 | 0.17 | Why? |
| Androgens | 1 | 2020 | 267 | 0.17 | Why? |
| DNA, Recombinant | 1 | 2017 | 94 | 0.17 | Why? |
| Myocytes, Cardiac | 2 | 2021 | 804 | 0.17 | Why? |
| Histone Deacetylase Inhibitors | 1 | 2018 | 79 | 0.17 | Why? |
| HEK293 Cells | 4 | 2020 | 8394 | 0.17 | Why? |
| Jurkat Cells | 1 | 2017 | 273 | 0.17 | Why? |
| Protein Isoforms | 1 | 2017 | 347 | 0.16 | Why? |
| DNA Helicases | 1 | 2017 | 203 | 0.16 | Why? |
| Methylation | 1 | 2017 | 332 | 0.16 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.15 | Why? |
| Cytotoxicity, Immunologic | 1 | 2017 | 287 | 0.15 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2021 | 584 | 0.15 | Why? |
| Repressor Proteins | 1 | 2017 | 232 | 0.15 | Why? |
| Cell Cycle Proteins | 1 | 2017 | 297 | 0.15 | Why? |
| Cell Line | 3 | 2020 | 12040 | 0.14 | Why? |
| Transfection | 1 | 2017 | 864 | 0.14 | Why? |
| Drug Evaluation, Preclinical | 3 | 2020 | 3347 | 0.13 | Why? |
| Single-Domain Antibodies | 1 | 2020 | 744 | 0.13 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.13 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.13 | Why? |
| Phosphoproteins | 2 | 2020 | 4346 | 0.13 | Why? |
| Triazoles | 1 | 2017 | 440 | 0.12 | Why? |
| Virus Activation | 1 | 2017 | 480 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Host-Pathogen Interactions | 4 | 2020 | 11041 | 0.12 | Why? |
| Drug Repositioning | 2 | 2021 | 5683 | 0.11 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.11 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.11 | Why? |
| Epigenesis, Genetic | 1 | 2017 | 711 | 0.11 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.11 | Why? |
| Transcriptome | 2 | 2021 | 3466 | 0.11 | Why? |
| Molecular Targeted Therapy | 1 | 2020 | 1579 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| T-Lymphocyte Subsets | 1 | 2017 | 1387 | 0.10 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.09 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.09 | Why? |
| Protein Binding | 3 | 2020 | 11430 | 0.08 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Diagnostic Tests, Routine | 1 | 2018 | 2643 | 0.08 | Why? |
| Vero Cells | 5 | 2020 | 14117 | 0.08 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Lymphoma, Large B-Cell, Diffuse | 1 | 2006 | 176 | 0.07 | Why? |
| A549 Cells | 2 | 2020 | 2066 | 0.07 | Why? |
| Humans | 20 | 2021 | 930598 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| Antibodies, Neutralizing | 2 | 2021 | 25288 | 0.07 | Why? |
| Cryoelectron Microscopy | 2 | 2020 | 2372 | 0.06 | Why? |
| Animals | 6 | 2020 | 78931 | 0.06 | Why? |
| Antiviral Agents | 5 | 2021 | 41703 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Phosphatidylinositols | 1 | 2020 | 29 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.06 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.05 | Why? |
| Biosynthetic Pathways | 1 | 2020 | 97 | 0.05 | Why? |
| SKP Cullin F-Box Protein Ligases | 1 | 2020 | 130 | 0.05 | Why? |
| Cyclin-Dependent Kinases | 1 | 2020 | 124 | 0.05 | Why? |
| Casein Kinase II | 1 | 2020 | 120 | 0.05 | Why? |
| Receptors, sigma | 1 | 2020 | 167 | 0.05 | Why? |
| Gene Knockout Techniques | 1 | 2020 | 347 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.05 | Why? |
| Cells, Cultured | 2 | 2021 | 5835 | 0.05 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 230 | 0.05 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2020 | 243 | 0.05 | Why? |
| Conserved Sequence | 1 | 2020 | 751 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 347 | 0.04 | Why? |
| Proto-Oncogene Proteins | 1 | 2020 | 340 | 0.04 | Why? |
| Protein Interaction Mapping | 1 | 2020 | 487 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Cloning, Molecular | 1 | 2020 | 1036 | 0.04 | Why? |
| Phosphorylation | 1 | 2020 | 1060 | 0.04 | Why? |
| Androgen Antagonists | 1 | 2020 | 404 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Cholesterol | 1 | 2020 | 660 | 0.04 | Why? |
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 624 | 0.04 | Why? |
| Protein Biosynthesis | 1 | 2020 | 653 | 0.04 | Why? |
| False Positive Reactions | 1 | 2021 | 1338 | 0.04 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.04 | Why? |
| Hepatitis C | 1 | 2006 | 1514 | 0.04 | Why? |
| Common Cold | 1 | 2020 | 645 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2020 | 1165 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Organoids | 1 | 2020 | 840 | 0.03 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.03 | Why? |
| Open Reading Frames | 1 | 2021 | 1898 | 0.03 | Why? |
| Limit of Detection | 1 | 2021 | 2698 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.03 | Why? |
| Heart | 1 | 2021 | 1791 | 0.03 | Why? |
| Protein Kinase Inhibitors | 1 | 2020 | 1585 | 0.03 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.03 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Myocardium | 1 | 2021 | 2323 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.02 | Why? |
| Protein Domains | 1 | 2020 | 6563 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.02 | Why? |
| Data Interpretation, Statistical | 1 | 2006 | 657 | 0.01 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2021 | 8041 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Female | 3 | 2020 | 380317 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Mice | 1 | 2020 | 21357 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.01 | Why? |
| Hepacivirus | 1 | 2006 | 1509 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Europe | 1 | 2006 | 12702 | 0.01 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.01 | Why? |
| Case-Control Studies | 1 | 2006 | 17671 | 0.01 | Why? |
| Adult | 2 | 2020 | 244371 | 0.01 | Why? |
| Male | 2 | 2020 | 367725 | 0.00 | Why? |
| Prevalence | 1 | 2006 | 25773 | 0.00 | Why? |
| Aged, 80 and over | 1 | 2006 | 88759 | 0.00 | Why? |
| Aged | 1 | 2006 | 215776 | 0.00 | Why? |
| Middle Aged | 1 | 2006 | 270681 | 0.00 | Why? |
Ott's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(481)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_